The Central Coast’s tech chops were in evidence in late October, when two firms netted more than $150 million in equity funding. Westlake Village biotech startup Arcutis Biotherapeutics raised $94.5 million in capital to send a plaque psoriasis drug through Phase 3 trials, with a technology that was at the center of a multibillion dollar…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
